Mimedx (MDXG) EBT (2011 - 2026)

Mimedx has disclosed EBT across 16 years of filings, most recently posting -$15.3 million for Q1 2026.

• EBT for Q1 2026 came in at -$15.3 million, down 278.02% year-over-year; the trailing twelve-month figure through Mar 2026 was $42.3 million (down 22.34% YoY), and the FY2025 annual result was $66.3 million, up 15.65% from the prior year.
• EBT came in at -$15.3 million for Q1 2026 at Mimedx, down from $21.8 million in the prior quarter.
• In the past five years, EBT ranged from a high of $23.2 million in Q2 2024 to a low of -$15.3 million in Q1 2026.
• The 5-year median for EBT is $9.9 million (2022), against an average of $7.0 million.
• Peak annual rise in EBT reached 10732.97% in 2022, while the deepest fall reached 505.72% in 2022.
• Mimedx's EBT stood at $9.9 million in 2022, then jumped by 41.13% to $13.9 million in 2023, then fell by 19.15% to $11.2 million in 2024, then soared by 93.75% to $21.8 million in 2025, then slumped by 170.34% to -$15.3 million in 2026.
• The last three EBT figures came in at -$15.3 million (Q1 2026), $21.8 million (Q4 2025), and $22.8 million (Q3 2025), per Business Quant data.